Matches in Wikidata for { <http://www.wikidata.org/entity/Q92997713> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q92997713 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92997713 description "scientific article published on 30 May 2019" @default.
- Q92997713 description "wetenschappelijk artikel" @default.
- Q92997713 description "наукова стаття, опублікована 30 травня 2019" @default.
- Q92997713 name "Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial" @default.
- Q92997713 name "Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial" @default.
- Q92997713 type Item @default.
- Q92997713 label "Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial" @default.
- Q92997713 label "Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial" @default.
- Q92997713 prefLabel "Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial" @default.
- Q92997713 prefLabel "Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial" @default.
- Q92997713 P1433 Q92997713-9996E2D4-2DD6-4244-A82B-FAABA4302DE4 @default.
- Q92997713 P1476 Q92997713-389AF3FF-78CC-4BA8-B272-3DDB40F3F664 @default.
- Q92997713 P2093 Q92997713-0231AC26-82C4-486B-8B6D-BDAF44547C5F @default.
- Q92997713 P2093 Q92997713-160812E5-01C5-40DB-8A84-408F5D911BFE @default.
- Q92997713 P2093 Q92997713-19C420A1-BDBB-4F21-A583-87A7DB90747D @default.
- Q92997713 P2093 Q92997713-1ECF8912-8E2C-4585-AF99-7BF76A42DA44 @default.
- Q92997713 P2093 Q92997713-54E31390-FAC7-49CC-8C19-938103BE7D61 @default.
- Q92997713 P2093 Q92997713-BE970B19-833D-45BD-B738-514028A7CA9A @default.
- Q92997713 P2093 Q92997713-D7AD1253-1907-4C46-85C3-7D85ED8E9F1B @default.
- Q92997713 P2093 Q92997713-E9DEA494-230E-4216-A4F7-946E438F4A76 @default.
- Q92997713 P304 Q92997713-F0C05275-5E1A-40A4-9428-1E4EB7151BD7 @default.
- Q92997713 P31 Q92997713-75E7376E-1B6C-43C9-A708-63AA47B94635 @default.
- Q92997713 P356 Q92997713-DA5D9B7D-FA61-4B8C-8EE6-307B25B96E65 @default.
- Q92997713 P433 Q92997713-01FAF790-BEBA-4377-9988-DFBB0D7D4088 @default.
- Q92997713 P478 Q92997713-73830197-F40E-4E65-83E0-E3FED8C54800 @default.
- Q92997713 P50 Q92997713-88534653-9D47-4294-9426-B6C2A70E7D89 @default.
- Q92997713 P50 Q92997713-B19E5BCE-BB73-4ABE-859A-27D88DC69623 @default.
- Q92997713 P50 Q92997713-C84B4D91-537F-4B0E-91CC-99510F8638AA @default.
- Q92997713 P50 Q92997713-FE03BD10-116A-4D09-8AEC-E3B1D2228348 @default.
- Q92997713 P50 Q92997713-FE4D05C4-26B8-4BA8-B69E-998BFEBC6688 @default.
- Q92997713 P577 Q92997713-44E37605-D06D-4D03-9A63-9AD5D0334AAC @default.
- Q92997713 P698 Q92997713-AE8DFD5C-ADCE-455C-9F3A-2FE59DEF993E @default.
- Q92997713 P921 Q92997713-C428A1E1-870E-413A-A7AC-A53C132184EB @default.
- Q92997713 P356 J.CLBC.2019.05.010 @default.
- Q92997713 P698 31235441 @default.
- Q92997713 P1433 Q332245 @default.
- Q92997713 P1476 "Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial" @default.
- Q92997713 P2093 "Aditya Bardia" @default.
- Q92997713 P2093 "Chelsea Andrews" @default.
- Q92997713 P2093 "Erica L Mayer" @default.
- Q92997713 P2093 "Laura M Spring" @default.
- Q92997713 P2093 "Rebecca Rees" @default.
- Q92997713 P2093 "Rie Kawabori Tahara" @default.
- Q92997713 P2093 "Sonia Pernas" @default.
- Q92997713 P2093 "William T Barry" @default.
- Q92997713 P304 "399-404" @default.
- Q92997713 P31 Q13442814 @default.
- Q92997713 P356 "10.1016/J.CLBC.2019.05.010" @default.
- Q92997713 P433 "6" @default.
- Q92997713 P478 "19" @default.
- Q92997713 P50 Q125212692 @default.
- Q92997713 P50 Q125263992 @default.
- Q92997713 P50 Q16887072 @default.
- Q92997713 P50 Q89253229 @default.
- Q92997713 P50 Q90198507 @default.
- Q92997713 P577 "2019-05-30T00:00:00Z" @default.
- Q92997713 P698 "31235441" @default.
- Q92997713 P921 Q412616 @default.